Long-term Combination Therapy With α-Blockers and 5α-Reductase Inhibitors in Benign Prostatic Hyperplasia: Patient Adherence and Causes of Withdrawal From Medication

Long-term Combination Therapy With α-Blockers and 5α-Reductase Inhibitors in Benign Prostatic Hyperplasia: Patient Adherence and Causes of Withdrawal From Medication

Purpose To investigate long-term therapeutic effects and patient adherence to a combination therapy of a 5α-reductase inhibitor and an α-blocker and to identify causes of withdrawal from medication in patients with clinical benign prostatic hyperplasia (BPH). Methods BPH patients with lower urinary...

Full description

Bibliographic Details
Main Authors: Hueih Ling Ong, Chun-Hou Liao, Hann-Chorng Kuo
Format: Article
Language:English
Published: Korean Continence Society 2016-12-01
Series:International Neurourology Journal
Subjects:
Adrenergic alpha-1 Receptor Antagonists
5-alpha Reductase Inhibitor
Medication Adherence
Adverse Effects
Online Access:http://www.einj.org/upload/pdf/inj-1632526-263.pdf

Internet

http://www.einj.org/upload/pdf/inj-1632526-263.pdf

Similar Items